Related Experiment Video
Updated: Oct 7, 2026

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
Published on: September 27, 2024
Influence of age on colorectal cancer's 5-year survival
M Kemppainen1, I Räihä, L Sourander
1Department of Geriatrics, University of Turku, Finland.
Abstract:
The aim of this study was to ascertain the 5-year survival figures of 171 consecutive colorectal cancer patients in southwestern Finland, the differences between various age groups, and which clinical variables predict poor outcome. The mean age at the time of diagnosis was 67 years in men and 69 years in women. The 5-year survival was lower in older patients, especially in those over 80 years with concomitant diseases. However, the colorectal cancer mortality did not differ between the three age groups: < 65, 65-80, > 80 years. Employing univariate analysis, a poor 5-year outcome was associated with metastases, and the outcome was excellent if the cancer was confined locally (p = 0.0001). As many as 26% of the patients in whom the cancer was confined to the bowel wall (Dukes B) at the time of operation died within 5 years. A poor survival rate was also found if the patients had emergency operations (p = 0.021). The postoperative mortality was 6%. Using logistic regression analysis, the poor 5-year survival rate was correlated strongly with metastasized cancer (p = 0.000) but less so with age (p = 0.040).
Related Concept Videos
Longitudinal Research
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion
Pharmacodynamics in Geriatric Patients: Effects of Age
Cancer Survival Analysis
